FindTrial
Sign In

A randomized study to compare dual trigger and hCG trigger in antagonist protocol in patients with low response

A randomized study to compare dual trigger and hCG trigger in antagonist protocol in patients with low response

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061977
Enrollment
Unknown
Registered
2022-07-14
Start date
2022-10-22
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Experimental group:HCG 10000IU + GnRHa 200ug dual trigger
Control group:HCG 10000IU trigger

Sponsors

CITIC Xiangya Reproductive and Genetic Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Poseidon criteria are used to judge patients with low ovarian prognosis; 2. Poseidon patients in groups 3 and 4, aged <= 45 years, 18 kg/m2 <= BMI <= 28 kg/m2.

Exclusion criteria

Exclusion criteria: Patients who conducted PGT, and donor egg cycles were excluded.

Design outcomes

Primary

MeasureTime frame
number of oocyt retrieval;—

Secondary

MeasureTime frame
mature oocyte;—

Countries

China

Contacts

Public ContactZhang Shunji

CITIC Xiangya Reproductive and Genetic Hospital

12214877@qq.com+86 186 8474 1202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026